Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$40.25 - $52.99 $12,075 - $15,897
300 New
300 $39,000
Q1 2022

Apr 22, 2022

SELL
$61.48 - $73.72 $3.04 Million - $3.65 Million
-49,525 Reduced 99.05%
475 $321,000
Q3 2019

Oct 24, 2019

SELL
$42.77 - $50.71 $213,850 - $253,550
-5,000 Reduced 9.09%
50,000 $68,000
Q2 2018

Aug 10, 2018

SELL
$50.53 - $62.98 $3.54 Million - $4.41 Million
-70,000 Reduced 56.0%
55,000 $95,000
Q1 2018

May 03, 2018

BUY
$59.92 - $68.98 $3.6 Million - $4.14 Million
60,000 Added 92.31%
125,000 $0
Q4 2017

Jan 31, 2018

BUY
$59.94 - $65.35 $299,700 - $326,750
5,000 Added 8.33%
65,000 $93,000
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $3.31 Million - $3.82 Million
60,000
60,000 $0

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Canal Insurance CO Portfolio

Follow Canal Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canal Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Canal Insurance CO with notifications on news.